Beta Drugs Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

197.62

157.87

124.85

79.46

65.32

Operating profit

33.53

31.20

25.18

15.31

11.75

Interest

1.05

0.84

0.41

0.77

0.64

Gross profit

34.21

31.40

25.63

15.15

11.53

EPS (Rs)

22.82

19.57

14.82

7.26

7.39

Other income

1.73

1.04

0.86

0.61

0.42

Stock adjustment

-6.97

-3.17

0.86

-1.38

0.20

Raw material

119.27

86.47

69.86

44.83

34.61

Power and fuel

-

-

-

-

-

Employee expenses

14.32

13.42

8.72

6.06

4.93

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

37.48

29.96

20.21

14.64

13.82

Provisions made

-

-

-

-

-

Depreciation

4.72

6.19

5.47

5.27

2.58

Taxation

7.55

6.39

5.92

2.90

1.85

Net profit / loss

21.94

18.82

14.25

6.98

7.10

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

9.61

9.61

9.61

9.61

9.61

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

16.96

19.76

20.17

19.27

17.99

GPM (%)

17.16

19.76

20.39

18.92

17.54

NPM (%)

11.00

11.84

11.33

8.71

10.80